No Data
No Data
Akero Therapeutics Insider Sold Shares Worth $4,381,867, According to a Recent SEC Filing
Akero Therapeutics(AKRO.US) Officer Sells US$4.38 Million in Common Stock
This Analyst Sees Potential Downside In Eli Lilly, Adjusts Model For Acquired IPR&D Charges
Akero Therapeutics(AKRO.US) Officer Sells US$117.02K in Common Stock
Form 144 | Akero Therapeutics(AKRO.US) Officer Proposes to Sell 351.9K in Common Stocks
SEC FILLINGS DISCLOSED/ Jul 1, $Akero Therapeutics(AKRO.US)$ Officer Jonathan Young intends to sell 15,000 shares of its common stock on Jul 1, with a total market value of approximately $351.9K. Jo
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Akero Therapeutics